TRIZIVIR
- Product NDC
- 53808-0990
- 11-digit product format
- 538080990
- Labeler code
- 53808
- Product ID
- 53808-0990_a6299f1c-1ddb-4da4-a38d-2cb34eca0c02
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- abacavir sulfate, lamivudine, and zidovudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- State of Florida DOH Central Pharmacy
- Application
- NDA021205
- Marketing category
- NDA
- Marketing start
- 2013-02-01
- Marketing end
- 0000-00-00
- Substance
- ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
- Active strength
- 300 mg/1; mg/1; mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53808-0990-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-7b76-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 2000 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53808-0990-1 | TRIZIVIR | 30 in 1 BLISTER PACK | TABLET, FILM COATED | 30 | 2 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53808-0990 | TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 2 | Legacy NDC, 1 package rows | 20140428_3354e50f-4dc5-413f-b5ae-87353ab8913d.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 307650 | abacavir sulfate 300 MG / lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet | PSN | 3354e50f-4dc5-413f-b5ae-87353ab8913d | 2 |
| 285028 | TRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet | PSN | 3354e50f-4dc5-413f-b5ae-87353ab8913d | 2 |
| 285028 | abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet [Trizivir] | SBD | 3354e50f-4dc5-413f-b5ae-87353ab8913d | 2 |
| 307650 | abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet | SCD | 3354e50f-4dc5-413f-b5ae-87353ab8913d | 2 |
| 307650 | abacavir (as abacavir sulfate) 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet | SY | 3354e50f-4dc5-413f-b5ae-87353ab8913d | 2 |
| 307650 | abacavir 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet | SY | 3354e50f-4dc5-413f-b5ae-87353ab8913d | 2 |
| 285028 | abacavir 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet [Trizivir] | SY | 3354e50f-4dc5-413f-b5ae-87353ab8913d | 2 |
| 285028 | Trizivir (abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG) Oral Tablet | SY | 3354e50f-4dc5-413f-b5ae-87353ab8913d | 2 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 53808-0990-1 | 53808099001 | 30 in 1 BLISTER PACK | Historical |